Literature DB >> 23727574

MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2.

Tao Yang1, Guo-Fei Zhang, Xiao-Fan Chen, Hai-Hua Gu, Shao-Zi Fu, Hong-Feng Xu, Qiang Feng, Yi-Ming Ni.   

Abstract

Micro RNAs are small, non-coding RNA molecules that regulate gene expression via either translational inhibition or mRNA degredation. Enhancer of zeste homolog 2 (EZH2)-mediated hypertrophic signaling is a major regulatory response to hypertrophic stimuli. In this study, we constructed AAC rat models and PE-induced hypertrophic cardiomyocytes. We demonstrated that miR-214 relative levels were upregulated, whereas EZH2 was downregulated in both vivo and vitro models. Further, one conserved base-pairing site in the EZH2 3'-untranslated region (UTR) was verified. Mutation of the site in the EZH2 3'-UTR completely blocked the negative effect of miR-214 on EZH2, suggesting that EZH2 is a direct target for miR-214 regulation. Using a gain-of-function approach, incorporating the lentivirus constructed miR-214 and its sponge, we demonstrated that miR-214 significantly regulated endogenous levels of EZH2 gene expression; whereas, changes in the expression of the Sine oculis homeobox homolog gene were induced by an adrenergic receptor agonist in the AAC rat model. Having made this study it is possible to conclude that the negative regulation of EZH2 expression contributed to miR-214-mediated cardiac hypertrophy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acta1; Cardiac hypertrophy; EZH2; Lenti-miR-214; Lenti-spg; MiRNAs; Myh7; Nppa; PRC2; Six1; UTR; actin alpha 1; beta-myosin heavy-chain gene; enhancer of zeste homolog 2; lentivirus-miR-214; lentivirus-miR-214 sponge; miR-214; microRNA-214; natriuretic peptide A; polycomb repressor complex 2; sine oculis homeobox homolog 1; untranslated region

Mesh:

Substances:

Year:  2013        PMID: 23727574     DOI: 10.1016/j.bbrc.2013.05.079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  The Role of MicroRNAs in the Cardiac Response to Exercise.

Authors:  Xiaojun Liu; Colin Platt; Anthony Rosenzweig
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

2.  MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.

Authors:  Yan-Qing Ding; Yu-Hong Zhang; Jing Lu; Bai Li; Wen-Jing Yu; Zhong-Bao Yue; Yue-Huai Hu; Pan-Xia Wang; Jing-Yan Li; Si-Dong Cai; Jian-Tao Ye; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2020-11-27       Impact factor: 7.169

3.  Marked disparity of microRNA modulation by cGMP-selective PDE5 versus PDE9 inhibitors in heart disease.

Authors:  Kristen M Kokkonen-Simon; Amir Saberi; Taishi Nakamura; Mark J Ranek; Guangshuo Zhu; Djahida Bedja; Michaela Kuhn; Marc K Halushka; Dong Ik Lee; David A Kass
Journal:  JCI Insight       Date:  2018-08-09

Review 4.  Novel insights into miRNA in lung and heart inflammatory diseases.

Authors:  Amit Kishore; Jana Borucka; Jana Petrkova; Martin Petrek
Journal:  Mediators Inflamm       Date:  2014-05-27       Impact factor: 4.711

Review 5.  Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases.

Authors:  Masaru Katoh
Journal:  Front Cell Dev Biol       Date:  2014-10-16

6.  MicroRNA-214 Mediates Isoproterenol-induced Proliferation and Collagen Synthesis in Cardiac Fibroblasts.

Authors:  Min Sun; Haiyi Yu; Youyi Zhang; Zijian Li; Wei Gao
Journal:  Sci Rep       Date:  2015-12-22       Impact factor: 4.379

7.  Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.

Authors:  Chun-Mei Tang; Fang-Zhou Liu; Jie-Ning Zhu; Yong-Heng Fu; Qiu-Xiong Lin; Chun-Yu Deng; Zhi-Qin Hu; Hui Yang; Xi-Long Zheng; Jian-Ding Cheng; Shu-Lin Wu; Zhi-Xin Shan
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

8.  NCK Associated Protein 1 Modulated by miRNA-214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia.

Authors:  Tayyab Adeel Afzal; Le Anh Luong; Dan Chen; Cheng Zhang; Feng Yang; Qishan Chen; Weiwei An; Edmund Wilkes; Kenta Yashiro; Pedro R Cutillas; Li Zhang; Qingzhong Xiao
Journal:  J Am Heart Assoc       Date:  2016-12-07       Impact factor: 5.501

9.  MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension.

Authors:  Sanghamitra Sahoo; Daniel N Meijles; Imad Al Ghouleh; Manuj Tandon; Eugenia Cifuentes-Pagano; John Sembrat; Mauricio Rojas; Elena Goncharova; Patrick J Pagano
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

10.  The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.

Authors:  Zhihua Wang; Xiao-Jing Zhang; Yan-Xiao Ji; Peng Zhang; Ke-Qiong Deng; Jun Gong; Shuxun Ren; Xinghua Wang; Iris Chen; He Wang; Chen Gao; Tomohiro Yokota; Yen Sin Ang; Shen Li; Ashley Cass; Thomas M Vondriska; Guangping Li; Arjun Deb; Deepak Srivastava; Huang-Tian Yang; Xinshu Xiao; Hongliang Li; Yibin Wang
Journal:  Nat Med       Date:  2016-09-12       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.